Related Experiment Video
Updated: Jun 17, 2026

The Double-H Maze: A Robust Behavioral Test for Learning and Memory in Rodents
Published on: July 8, 2015
WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction
Lianne Robinson1, Anushka V Goonawardena, Roger Pertwee
1School of Medical Sciences, College of Life Science and Medicine, University of Aberdeen, Foresterhill, Aberdeen, UK.
Synthetic cannabinoid WIN55,212-2 (WIN-2) impairs long-term spatial memory in rats, potentially via non-CB(1) receptor pathways. This memory deficit is linked to reduced cholinergic activity and reversed by rivastigmine, suggesting a novel mechanism of action.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Science
Background:
- Cannabinoids acting on CB(1) receptors are known to impair learning and memory.
- Novel non-CB(1) receptors sensitive to synthetic cannabinoids like WIN55,212-2 (WIN-2) raise questions about the mechanism of WIN-2 induced memory deficits.
- Understanding cannabinoid effects requires investigating transmitter systems modulated by these compounds, especially given the limited availability of specific antagonists.
Purpose of the Study:
- To investigate the effects of WIN-2 on the acquisition of spatial reference memory in rats.
- To determine if WIN-2 induced learning and memory deficits are mediated by CB(1) receptor activation.
- To explore the underlying neurochemical mechanisms, particularly cholinergic pathways, involved in WIN-2's effects on memory.
Main Methods:
- Spatial reference memory was assessed using the water maze task in rats.
- WIN-2 was administered intraperitoneally (i.p.) at doses of 1 mg/kg and 3 mg/kg prior to training.
- The effects of WIN-2 were evaluated in the presence of CB(1) antagonists (Rimonabant, AM281) and a cholinesterase inhibitor (rivastigmine).
Main Results:
- WIN-2 administration (1 mg/kg and 3 mg/kg) significantly impaired long-term spatial memory but not short-term memory.
- The memory deficits induced by WIN-2 were not reversed by CB(1) antagonists Rimonabant or AM281.
- Rivastigmine treatment reversed the WIN-2 induced long-term memory impairment, while not affecting MK801 induced deficits, indicating specificity.
Conclusions:
- WIN-2 impairs long-term spatial reference memory in rats through a mechanism that does not appear to involve CB(1) receptors.
- The findings suggest that WIN-2 may reduce cholinergic activation, contributing to the observed memory deficits.
- This study highlights a potential non-CB(1) mediated pathway for cannabinoid-induced memory impairment, modulated by the cholinergic system.
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

